AAM
ONC

Advisors Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Advisors Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-280
Closed -$62.9K – 1530
2024
Q3 		$62.9K Sell
280
-214
-43% -$38.5K ﹤0.01% 1286
2024
Q2 		$70.5K Sell
494
-149
-23% -$23K ﹤0.01% 1246
2024
Q1 		$101K Sell
643
-214
-25% -$34.5K ﹤0.01% 1218
2023
Q4 		$155K Sell
857
-205
-19% -$37.1K ﹤0.01% 1151
2023
Q3 		$191K Buy
1,062
+183
+21% +$36.2K ﹤0.01% 1122
2023
Q2 		$157K Buy
879
+18
+2% +$4.14K ﹤0.01% 1159
2023
Q1 		$186K Sell
861
-30
-3% -$7.2K ﹤0.01% 1132
2022
Q4 		$196K Buy
891
+109
+14% +$20K ﹤0.01% 1129
2022
Q3 		$105K Sell
782
-491
-39% -$84.3K ﹤0.01% 1255
2022
Q2 		$206K Buy
1,273
+29
+2% +$4.53K ﹤0.01% 1160
2022
Q1 		$235K Buy
1,244
+262
+27% +$55.7K ﹤0.01% 1196
2021
Q4 		$266K Buy
982
+132
+16% +$44.6K ﹤0.01% 1168
2021
Q3 		$309K Sell
850
-205
-19% -$67K ﹤0.01% 1142
2021
Q2 		$362K Sell
1,055
-657
-38% -$218K 0.01% 1090
2021
Q1 		$596K Sell
1,712
-175
-9% -$57.9K 0.01% 976
2020
Q4 		$488K Buy
1,887
+370
+24% +$102K 0.01% 976
2020
Q3 		$435K Buy
1,517
+217
+17% +$51K 0.01% 954
2020
Q2 		$245K Buy
1,300
+19
+1% +$3.09K ﹤0.01% 1116
2020
Q1 		$158K Buy
1,281
+346
+37% +$54.1K ﹤0.01% 1151
2019
Q4 		$155K Buy
935
+653
+232% +$108K ﹤0.01% 1257
2019
Q3 		$34.5K Buy
282
+82
+41% +$10.9K ﹤0.01% 1437
2019
Q2 		$24.8K Buy
200
+80
+67% +$10.2K ﹤0.01% 1455
2019
Q1 		$15.8K Buy
+120
New +$16.2K ﹤0.01% 1489

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Advisors Asset Management's ONC Position: Q4 2024 in Review

Advisors Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2024, closing a stake of 280 shares — an estimated $62.9K sold.

Advisors Asset Management first reported a position in ONC in Q1 2019 and held it in 23 quarters. The position peaked at $596K in Q1 2021. 228 funds tracked by Wall St. Rank hold ONC as of Q4 2024.

  • Advisors Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2024 after selling out during the quarter.
  • Advisors Asset Management sold 280 BeOne Medicines Ltd shares in Q4 2024, an estimated $62.9K.
  • Advisors Asset Management first reported a position in BeOne Medicines Ltd in Q1 2019 and held it in 23 quarters.
  • Advisors Asset Management's BeOne Medicines Ltd position peaked at $596K in Q1 2021.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2024.

Based on Advisors Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.